TY - JOUR
T1 - Target-responsive vasoactive probes for ultrasensitive molecular imaging
AU - Ohlendorf, Robert
AU - Wiśniowska, Agata
AU - Desai, Mitul
AU - Barandov, Ali
AU - Slusarczyk, Adrian L.
AU - Li, Nan
AU - Jasanoff, Alan
N1 - Funding Information:
We acknowledge grants from the National Institutes of Health (R24 MH109081, U01 NS103470, and UF1 NS107712) to A.J. R.O. was funded by a fellowship from the Deutsche Forschungsgemeinschaft. A.W. was funded by the Advanced Multimodal Neuroimaging Training Program at the Massachusetts General Hospital (R90 DA023427) and a fellowship from Harvard-MIT Health Sciences and Technology program. We thank Dr. Peter Harvey for help with fluorescence microscopy, and are grateful to Alla Leshinsky of the MIT Koch Institute Biopolymers and Proteomics Laboratory for assistance with peptide synthesis.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12/1
Y1 - 2020/12/1
N2 - The ability to monitor molecules volumetrically throughout the body could provide valuable biomarkers for studies of healthy function and disease, but noninvasive detection of molecular targets in living subjects often suffers from poor sensitivity or selectivity. Here we describe a family of potent imaging probes that can be activated by molecules of interest in deep tissue, providing a basis for mapping nanomolar-scale analytes without the radiation or heavy metal content associated with traditional molecular imaging agents. The probes are reversibly caged vasodilators that induce responses detectable by hemodynamic imaging; they are constructed by combining vasoactive peptides with synthetic chemical appendages and protein blocking domains. We use this architecture to create ultrasensitive biotin-responsive imaging agents, which we apply for wide-field mapping of targets in rat brains using functional magnetic resonance imaging. We also adapt the sensor design for detecting the neurotransmitter dopamine, illustrating versatility of this approach for addressing biologically important molecules.
AB - The ability to monitor molecules volumetrically throughout the body could provide valuable biomarkers for studies of healthy function and disease, but noninvasive detection of molecular targets in living subjects often suffers from poor sensitivity or selectivity. Here we describe a family of potent imaging probes that can be activated by molecules of interest in deep tissue, providing a basis for mapping nanomolar-scale analytes without the radiation or heavy metal content associated with traditional molecular imaging agents. The probes are reversibly caged vasodilators that induce responses detectable by hemodynamic imaging; they are constructed by combining vasoactive peptides with synthetic chemical appendages and protein blocking domains. We use this architecture to create ultrasensitive biotin-responsive imaging agents, which we apply for wide-field mapping of targets in rat brains using functional magnetic resonance imaging. We also adapt the sensor design for detecting the neurotransmitter dopamine, illustrating versatility of this approach for addressing biologically important molecules.
UR - http://www.scopus.com/inward/record.url?scp=85084627558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084627558&partnerID=8YFLogxK
U2 - 10.1038/s41467-020-16118-7
DO - 10.1038/s41467-020-16118-7
M3 - Article
C2 - 32404879
AN - SCOPUS:85084627558
SN - 2041-1723
VL - 11
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 2399
ER -